During the past decade, Rex Hematology Oncology Associates-Garner conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rex Hematology Oncology Associates-Garner" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Rex Hematology Oncology Associates-Garner" are "Anatomic Stage II Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIIA Breast Cancer AJCC v8" (2 trials) and "Invasive Breast Carcinoma" (2 trials). Many other conditions were trialed in "Rex Hematology Oncology Associates-Garner" in a lesser frequency.

Most popular intervention types in "Rex Hematology Oncology Associates-Garner" are "Drug" (8 trials), "Other" (5 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Trastuzumab Emtansine" (2 trials), "Aspirin" (1 trials), "Carboplatin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rex Hematology Oncology Associates-Garner" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Rex Hematology Oncology Associates-Garner". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rex Hematology Oncology Associates-Garner, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rex Hematology Oncology Associates-Garner, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".